FTLD vs AD | ||||||||
All participants 49 FTLD vs 97 AD | No copathology 38 FTLD vs 97 AD | |||||||
AUC (95% CI) | Best-fit cut-off | Se (%) | Sp (%) | AUC (95% CI) | Best-fit cut-off | Se (%) | Sp (%) | |
sAPPĪ² | 0.66 (0.57 to 0.75) | 393 ng/mL | 85 | 27 | 0.68 (0.58 to 0.77) | 393 ng/mL | 85 | 29 |
YKL-40 | 0.57 (0.48 to 0.67) | 336 ng/mL | 85 | 16 | 0.58 (0.49 to 0.68) | 339 ng/mL | 87 | 18 |
sAPPĪ²:YKL-40 ratio | 0.70 (0.61 to 0.79) | 1.51 | 86 | 39 | 0.71 (0.62 to 0.81) | 1.51 | 86 | 55 |